Multiple routes of complement activation by Mycobacterium bovis BCG

Molecular Immunology

Volumn 46, Issue 16, 2009, Pages 3367-3378

  Carroll, Maria V ^a,b   Lack, Nathan ^b   Sim, Edith ^b   Krarup, Anders ^a   Sim, Robert B ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alternative pathway; C1q; C3; Classical pathway; Complement; Factor H; Ficolins; Lectin pathway; Mannose binding lectin; Mycobacterium bovis BCG; Proteases

Indexed keywords

BCG VACCINE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; FICOLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN TISSUE; INCUBATION TIME; MACROMOLECULE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; SHEEP ERYTHROCYTE; TUBERCULOSIS;

ANTIBODIES, BACTERIAL; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C3B; COMPLEMENT FACTOR H; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LECTINS; MACROPHAGES; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MYCOBACTERIUM BOVIS;

CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 70349595391     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.07.015     Document Type: Article

References (65)

1. Andersen P., Askgaard D., Ljungqvist L., Bennedsen J., and Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 59 (1991) 1905-1910
2. Aoyagi Y., Adderson E.E., Min J.G., Matsushita M., Fujita T., Takahashi S., Okuwaki Y., and Bohnsack J.F. Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J. Immunol. 174 (2005) 418-425
3. Armstrong J.A., and Hart P.D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142 (1975) 1-16
4. Bardana Jr. E.J., McClatchy J.K., Farr R.S., and Minden P. Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin. Exp. Immunol. 13 (1973) 65-77
5. Besra G.S. Preparation of cell-wall fractions from mycobacteria. In: Parish T., and Stoker N.G. (Eds). Methods Molecular Biology Mycobacterial Protocols vol. 101 (1998) 91-107
6. Borsos T., and Rapp H.J. Immune hemolysis: a simplified method for the preparation of EAC′4 with guinea pig or with human complement. J. Immunol. 99 (1967) 263-268
7. China B., Sory M.P., N'Guyen B.T., De Bruyere M., and Cornelis G.R. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 61 (1993) 3129-3136
8. Clas F., and Loos M. Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota. Infect. Immun. 31 (1981) 1138-1144
9. Clemens D.L., and Horwitz M.A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181 (1995) 257-270
10. Cywes C., Godenir N.L., Hoppe H.C., Scholle R.R., Steyn L.M., Kirsch R.E., and Ehlers M.R. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 64 (1996) 5373-5383
11. Daffe M., and Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39 (1998) 131-203
12. Daffe M., and Etienne G. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tuber Lung Dis. 79 (1999) 153-169
13. Dave S., Brooks-Walter A., Pangburn M.K., and McDaniel L.S. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69 (2001) 3435-3437
14. Diaz A., Ferreira A., and Sim R.B. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J. Immunol. 158 (1997) 3779-3786
15. Dodds A.W. Small-scale preparation of complement components C3 and C4. Methods Enzymol. 223 (1993) 46-61
16. Endo Y., Matsushita M., and Fujita T. Role of ficolin in innate immunity and its molecular basis. Immunobiology 212 (2007) 371-379
17. Fairbanks G., Steck T.L., and Wallach D.F. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10 (1971) 2606-2617
18. Ferguson J.S., Weis J.J., Martin J.L., and Schlesinger L.S. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect. Immun. 72 (2004) 2564-2573
19. Fick Jr. R.B., Robbins R.A., Squier S.U., Schoderbek W.E., and Russ W.D. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr. Res. 20 (1986) 1258-1268
20. Frederiksen P.D., Thiel S., Larsen C.B., and Jensenius J.C. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand. J. Immunol. 62 (2005) 462-473
21. Gadd K.J., and Reid K.B. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab′)2 region of rabbit IgG antibody in immune aggregates. Immunology 42 (1981) 75-82
22. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., Duthoy S., Grondin S., Lacroix C., Monsempe C., Simon S., Harris B., Atkin R., Doggett J., Mayes R., Keating L., Wheeler P.R., Parkhill J., Barrell B.G., Cole S.T., Gordon S.V., and Hewinson R.G. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7877-7882
23. Hallstrom T., Zipfel P.F., Blom A.M., Lauer N., Forsgren A., and Riesbeck K. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181 (2008) 537-545
24. Hetland G., and Wiker H.G. Antigen 85C on Mycobacterium bovis, BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products. Immunology 82 (1994) 445-449
25. Hetland G., Wiker H.G., Hogasen K., Hamasur B., Svenson S.B., and Harboe M. Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin. Diagn. Lab. Immunol. 5 (1998) 211-218
26. Horstmann R.D., Sievertsen H.J., Knobloch J., and Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1657-1661
27. Jagels M.A., Ember J.A., Travis J., Potempa J., Pike R., and Hugli T.E. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor. Adv. Exp. Med. Biol. 389 (1996) 155-164
28. Johnstone A.P., and Thorpe R. Immunochemistry in Practice (1996), Wiley-Blackwell
29. Kang Y.H., Tan L.A., Carroll M.V., Gentle M.E., and Sim R.B. Target pattern recognition by complement proteins of the classical and alternative pathways. In: Kishore U. (Ed). Advances in Experimental Medicine and Biology: Target Pattern Recognition in Innate Immunity vol. 653 (2009), Landes Bioscience and Springer Science, Austin, TX 117-128
30. Kertesz Z., Yu B.B., Steinkasserer A., Haupt H., Benham A., and Sim R.B. Characterization of binding of human beta 2-glycoprotein I to cardiolipin. Biochem. J. 310 Pt 1 (1995) 315-321
31. Krarup A., Mitchell D.A., and Sim R.B. Recognition of acetylated oligosaccharides by human L-ficolin. Immunol. Lett. 118 (2008) 152-156
32. Krarup A., Sorensen U.B., Matsushita M., Jensenius J.C., and Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect. Immun. 73 (2005) 1052-1060
33. Krarup A., Thiel S., Hansen A., Fujita T., and Jensenius J.C. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279 (2004) 47513-47519
34. Krarup A., Wallis R., Presanis J.S., Gal P., and Sim R.B. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS ONE 2 (2007) e623
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Latsch M., Mollerfeld J., Ringsdorf H., and Loos M. Studies on the interaction of C1q, a subcomponent of the first component of complement, with porins from Salmonella minnesota incorporated into artificial membranes. FEBS Lett. 276 (1990) 201-204
37. Matsushita M., Endo Y., and Fujita T. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164 (2000) 2281-2284
38. Matsushita M., Endo Y., Hamasaki N., and Fujita T. Activation of the lectin complement pathway by ficolins. Int. Immunopharmacol. 1 (2001) 359-363
39. Matsushita M., Endo Y., Taira S., Sato Y., Fujita T., Ichikawa N., Nakata M., and Mizuochi T. A novel human serum lectin with collagen and fibrinogen-like domains that functions as an opsonin. J. Biol. Chem. 271 (1996) 2448-2454
40. Matsushita M., and Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176 (1992) 1497-1502
41. Matsushita M., and Fujita T. Ficolins and the lectin complement pathway. Immunol. Rev. 180 (2001) 78-85
42. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., and Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168 (2002) 3502-3506
43. Mattow J., Schaible U.E., Schmidt F., Hagens K., Siejak F., Brestrich G., Haeselbarth G., Muller E.C., Jungblut P.R., and Kaufmann S.H. Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 24 (2003) 3405-3420
44. Mayilyan K.R., Presanis J.S., Arnold J.N., and Sim R.B. Discrete MBL-MASP complexes show wide inter-individual variability in concentration: data from UK vs Armenian populations. Int. J. Immunopathol. Pharmacol. 19 (2006) 567-580
45. Meri T., Hartmann A., Lenk D., Eck R., Wurzner R., Hellwage J., Meri S., and Zipfel P.F. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 70 (2002) 5185-5192
46. Mueller-Ortiz S.L., Wanger A.R., and Norris S.J. Mycobacterial protein HbhA binds human complement component C3. Infect. Immun. 69 (2001) 7501-7511
47. Nagai S., Wiker H.G., Harboe M., and Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect. Immun. 59 (1991) 372-382
48. Ram S., McQuillen D.P., Gulati S., Elkins C., Pangburn M.K., and Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 188 (1998) 671-680
49. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., and Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187 (1998) 743-752
50. Ramanathan V.D., Curtis J., and Turk J.L. Activation of the alternative pathway of complement by mycobacteria and cord factor. Infect. Immun. 29 (1980) 30-35
51. Ramu P., Tanskanen R., Holmberg M., Lahteenmaki K., Korhonen T.K., and Meri S. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett. 581 (2007) 1716-1720
52. Reid K.B. C1q. Methods Enzymol. 82 Pt A (1982) 319-324
53. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L., and Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 43 (2006) 193-201
54. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150 (1993) 2920-2930
55. Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., and Horwitz M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144 (1990) 2771-2780
56. Schlesinger L.S., and Horwitz M.A. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect. Immun. 62 (1994) 280-289
57. Schneider M.C., Exley R.M., Chan H., Feavers I., Kang Y.H., Sim R.B., and Tang C.M. Functional significance of factor H binding to Neisseria meningitidis. J. Immunol. 176 (2006) 7566-7575
58. Sim R.B., Day A.J., Moffatt B.E., and Fontaine M. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 223 (1993) 13-35
59. Sturgill-Koszycki S., Schaible U.E., and Russell D.G. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 15 (1996) 6960-6968
60. Sugimoto R., Yae Y., Akaiwa M., Kitajima S., Shibata Y., Sato H., Hirata J., Okochi K., Izuhara K., and Hamasaki N. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J. Biol. Chem. 273 (1998) 20721-20727
61. Taira S., Kodama N., Matsushita M., and Fujita T. Opsonic function and concentration of human serum ficolin/P35. Fukushima J. Med. Sci. 46 (2000) 13-23
62. Venisse A., Berjeaud J.M., Chaurand P., Gilleron M., and Puzo G. Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry. J. Biol. Chem. 268 (1993) 12401-12411
63. Whaley K., and Ruddy S. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science 193 (1976) 1011-1013
64. Whaley K., and Ruddy S. Modulation of the alternative complement pathways by beta 1 H globulin. J. Exp. Med. 144 (1976) 1147-1163
65. Wingrove J.A., DiScipio R.G., Chen Z., Potempa J., Travis J., and Hugli T.E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J. Biol. Chem. 267 (1992) 18902-18907